Here are relevant reports on : route-optimization-market
-
Mainframe Modernization Market by Software (Application Modernization, Mainframe Optimization), Modernization Services (Application Modernization, Optimization, Operations, Mainframe-as-a-Service), Vertical, Region - Global Forecast to 2030
The mainframe modernization market is projected to expand from USD 8.39 billion in 2025 to USD 13.34 billion by 2030, at a CAGR of 9.7%, during the forecast period. The report profiles key players such as IBM (US), TCS (India), Capgemini (France), Atos (France), AWS (US), Micro Focus (UK), BMC Software (US), Infosys (India), Wipro (India), and HCL Tech (India).
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Network Performance Optimization Market : Worldwide Market Forecast and Analysis (2014–2019)
Enterprise networks are continuously evolving into increasingly complex systems. They are dependent on reliable and robust performance of countless interconnected applications and devices. Networks have become the lifeblood of business and the conduit by which customers, partners, and employees share data and conduct business. Moreover, increased network complexity, converging technologies, and growing implementation of virtualization are expected to transform network management technologies, tools, and practices, and virtual networking installed as a part of server virtualization will progressively influence network managers. Network performance management includes monitoring, configuring, troubleshooting, controlling, and administrating the network-based business operations. The network performance management report covers various solutions such as bandwidth management, capacity planning and prediction management, and troubleshooting.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Petroleum Fuel Optimization Technologies Market - By Technologies and Geography: Trends & Forecasts to 2019
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Optimization Market: Worldwide Market Forecast and Analysis (2014–2019)
Enterprise networks are continuously evolving into increasingly complex systems. They are dependent on reliable and robust performance of countless interconnected applications and devices. Networks have become the lifeblood of business and the conduit by which customers, partners, and employees share data and conduct business. Moreover, increased network complexity, converging technologies, and growing implementation of virtualization are expected to transform network management technologies, tools, and practices, and virtual networking installed as a part of server virtualization will progressively influence network managers. Network performance management includes monitoring, configuring, troubleshooting, controlling, and administrating the network-based business operations. The network performance management report covers various solutions such as bandwidth management, capacity planning and prediction management, and troubleshooting.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Generative Engine Optimization (GEO) Market 2032: Size, Share & Growth Report
Generative Engine Optimization (GEO) Market
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Europe Pharmaceutical Drug Delivery Market by Route of Administration [Oral (Tablet, Capsule), Injector, Topical (Cream, Transdermal Patch), Transmucosal, Nasal], Application [Cancer, Diabetes], Care Setting [Hospital, Homecare]- Forecast to 2031
The Europe Pharmaceutical drug delivery market, valued at USD501.62 billion in 2025, stood at USD519.62 billion in 2026 and is projected to advance at a resilient CAGR of 6.2% from 2026 to 2031, culminating in a forecasted valuation of USD703.19 billion by the end of the period. The market growth is driven by rising use of biologics and biosimilars, an increasing prevalence of chronic diseases, and growing acceptance of innovative drug delivery devices, including auto-injectors, prefilled syringes, and inhalation systems.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Monoclonal Antibodies Market by Animal Type (Canine, Feline, Swine), Product (Cytopoint, Librela, Solensia), Therapy Area (Dermatology, Infectious, Osteoarthritis, Pain, Oncology, Others), Route of Administration - Global Forecast to 2030
The global veterinary monoclonal antibodies market, valued at US$1.52 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$3.06 billion by the end of the period. Opportunities in the market involve expanding therapeutic uses beyond dermatology and osteoarthritis, as well as developing new administration routes for monoclonal antibodies.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Pharmaceuticals Market by Product (Drugs, mAbs, Immunomodulators, Medicated Feed Additives), Route of Administration, Formulation Type, Indication, Animal Type (Companion, Livestock), Distribution Channel, End User—Global Forecast to 2031
The global veterinary pharmaceuticals market, valued at USD 27.41 billion in 2025, stood at USD 28.98 billion in 2026 and is projected to advance at a resilient CAGR of 6.3% from 2026 to 2031, culminating in a forecasted valuation of USD 39.37 billion by the end of the period. The market growth is driven by rising pet ownership, increasing livestock production, and higher demand for disease management drugs. Expanding awareness of animal health, growing expenditure on companion animals, and advancements in anti-infectives, parasiticides, and dermatology treatments are further supporting steady market expansion across developed and emerging regions.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Companion Animal Pharmaceuticals Market by Animal Type (Dogs, Cats, Horses), Route of Administration (Oral, Injectable, Topical), Indication (Antibiotics, Parasiticides), Distribution Channel (Veterinary Hospitals & Clinics) & Region - Global Forecasts to 2027
The global companion animal pharmaceuticals market in terms of revenue was estimated to be worth $14.4 billion in 2022 and is poised to reach $19.6 billion by 2027, growing at a CAGR of 6.3% from 2022 to 2027. Major players operating in the market Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), Ceva Santé Animale (France), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals plc (UK) are some of the market players.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Fusion Biopsy Market by Route Type (Transrectal, Transperineal), Product (Equipment, Consumables), Application (Prostate Cancer), End User (Hospitals), and Region - Global Forecast to 2029
The global fusion biopsy market, valued at US$0.61 billion in 2023, stood at US$0.65 billion in 2024 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2029, culminating in a forecasted valuation of US$0.91 billion by the end of the period. Some main drivers for the growth of the fusion biopsy market are the growing prevalence of prostate cancer, since it's among one of the most common serious health concerns for males on a global scale.
- Published: December 2024
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
